Use of systemic and biological therapy in patients with moderate-to-severe psoriasis.

Mie S LiljendahlNikolai LoftTri-Long NguyenLone SkovAlexander Egeberg

Published in: Clinical and experimental dermatology (2023)

This study found that nearly 37.7% of the patients with moderate-to-severe psoriasis do not receive systemic treatment even though they would qualify for this. Further, for patients treated with conventional systemics, the drug survival decreased during the observation period.

Keyphrases

drug induced
high intensity
early onset
emergency department
atopic dermatitis
free survival